Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...

CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and ...

There’s a profound difference between depriving yourself—believing certain foods are off-limits because they’re “bad”—and ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug ... are "no anomalies […] that would cause the board to adopt an alternative view" of its prospects.

District residents will be able to vote on the budget, and school board candidates, on May 20. The proposal includes a tax levy of $36,803,460, an increase of 3.25% but under the state-imposed cap ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 5, 2025, the moon is 9 days old and is in the Waxing Gibbous phase of its lunar cycle.

These must-haves deserve to be in your collection, and each one has been hand-picked for this list of the best board games by industry experts When you purchase through links on our site ...

Roaches played a role in the temporarily closure of one cafe, and a few other inspections that failed to meet standards.

We are pleased to share the May 2025 issue of Wilson Sonsini’s Sustainability and ESG Advisory Practice Update. Each issue combines news, key ...